FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206421578> ?p ?o ?g. }

• W3206421578 endingPage "A752" @default.
• W3206421578 startingPage "A752" @default.
• W3206421578 abstract "TOPIC: Critical Care TYPE: Medical Student/Resident Case Reports INTRODUCTION: BH is a 41-year-old Nepalese male with a history of ulcerative colitis (recently on adalimumab) and type two diabetes mellitus was transferred for the evaluation of ECMO. He presented to an outside hospital two days prior with a complaint of fevers, hemoptysis, and five-pound weight loss over one month. Despite pre-biologic testing showing indeterminate interferon, negative acid fast culture and a normal chest x-ray, a CT scan of his chest revealed diffuse miliary pattern, consistent with tuberculosis. CASE PRESENTATION: On arrival, the patient was intubated and required norepinephrine, vasopressin and phenylephrine to maintain mean arterial pressures over 65 mmHg. White blood cell count was 5.75 K/uL, lactic acid was 6.5 mmol/L, troponin was 0.5 ng/mL, brain natriuretic peptide was 66,716 pg/mL, ALT of 2827 unit/L and AST greater than 7000 unit/L, concerning for shock. Patient was anuric for which continuous renal replacement therapy was initiated. An echocardiogram showed an ejection fraction of 20-25%. Dobutamine was started due to a rising lactate despite adequate blood pressure. Patient was not a candidate for ECMO given presumed TB infection. Patient was started on Amikacin, Moxifloxacin, Meropenem, Ethambutol and Amphotericin. After a week, he was weaned from pressors and was extubated. He also regained renal function. A repeat echocardiogram two weeks following demonstrated improvement of ejection fraction to 50%. Acid fast bacillus testing confirmed tuberculosis. DISCUSSION: Adalimumab, a TNF-α inhibitor, are among biologic medications that are used in treatment of ulcerative colitis. Although one of its main infectious complications is tuberculosis, there can be other side effects including initiation of heart failure, cytopenia, and elevated transaminases [4]. All mentioned side effects may worsen the clinical picture of septic shock. There are only a handful of cases, some in pediatric literature [3], that conveys the degree of sepsis related to disseminated tuberculosis. Most literature of disseminated tuberculosis are often in the setting of human immunodeficiency virus or in pediatrics [4]. CONCLUSIONS: This case highlights the atypical presentation of disseminated tuberculosis masquerading as septic shock in the setting of recent adalimumab use. Despite the negative screen, it may be possible to develop tuberculosis during biologic therapy. Our case suggests that it may be of utility to retest for tuberculosis during therapy in individuals who may be at high risk for developing tuberculosis or those with indeterminant interferon results. REFERENCE #1: George S, Papa L, Sheils L, Magnussen CR. Septic shock due to disseminated tuberculosis. Clin Infect Dis. 1996 Jan;22(1):188-9. doi: 10.1093/clinids/22.1.188. PMID: 8825004. REFERENCE #2: Hess S, Hospach T, Nossal R, Dannecker G, Magdorf K, Uhlemann F. Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent. Eur J Pediatr. 2011 Oct;170(10):1337-42. doi: 10.1007/s00431-011-1501-y. Epub 2011 May 31. PMID: 21625932. REFERENCE #3: Mark S. Godfrey, Lloyd N. Friedman, Tuberculosis and Biologic Therapies: Anti-Tumor Necrosis Factor-α and Beyond, Clinics in Chest Medicine, Volume 40, Issue 4, 2019, Pages 721-739, ISSN 0272-5231, ISBN 9780323682152, https://doi.org/10.1016/j.ccm.2019.07.003.[4] Scheinfeld N. Adalimumab: a review of side effects. Expert Opin Drug Saf. 2005 Jul;4(4):637-41. doi: 10.1517/14740338.4.4.637. PMID: 16011443. DISCLOSURES: No relevant relationships by Saad Ashraf, source=Web Response No relevant relationships by Fiyad Haniff, source=Web Response No relevant relationships by ANDRY VAN DE LOUW, source=Web Response" @default.
• W3206421578 created "2021-10-25" @default.
• W3206421578 creator A5033429301 @default.
• W3206421578 creator A5042873649 @default.
• W3206421578 creator A5056320736 @default.
• W3206421578 date "2021-10-01" @default.
• W3206421578 modified "2023-09-25" @default.
• W3206421578 title "A SHOCKING CASE OF DISSEMINATED TB" @default.
• W3206421578 doi "https://doi.org/10.1016/j.chest.2021.07.711" @default.
• W3206421578 hasPublicationYear "2021" @default.
• W3206421578 type Work @default.
• W3206421578 sameAs 3206421578 @default.
• W3206421578 citedByCount "1" @default.
• W3206421578 countsByYear W32064215782021 @default.
• W3206421578 crossrefType "journal-article" @default.
• W3206421578 hasAuthorship W3206421578A5033429301 @default.
• W3206421578 hasAuthorship W3206421578A5042873649 @default.
• W3206421578 hasAuthorship W3206421578A5056320736 @default.
• W3206421578 hasBestOaLocation W32064215781 @default.
• W3206421578 hasConcept C126322002 @default.
• W3206421578 hasConcept C141071460 @default.
• W3206421578 hasConcept C142724271 @default.
• W3206421578 hasConcept C164705383 @default.
• W3206421578 hasConcept C2776228421 @default.
• W3206421578 hasConcept C2776376669 @default.
• W3206421578 hasConcept C2776850375 @default.
• W3206421578 hasConcept C2777628635 @default.
• W3206421578 hasConcept C2777682441 @default.
• W3206421578 hasConcept C2777975735 @default.
• W3206421578 hasConcept C2778198053 @default.
• W3206421578 hasConcept C2778384902 @default.
• W3206421578 hasConcept C2781069245 @default.
• W3206421578 hasConcept C42219234 @default.
• W3206421578 hasConcept C500558357 @default.
• W3206421578 hasConcept C71924100 @default.
• W3206421578 hasConcept C78085059 @default.
• W3206421578 hasConceptScore W3206421578C126322002 @default.
• W3206421578 hasConceptScore W3206421578C141071460 @default.
• W3206421578 hasConceptScore W3206421578C142724271 @default.
• W3206421578 hasConceptScore W3206421578C164705383 @default.
• W3206421578 hasConceptScore W3206421578C2776228421 @default.
• W3206421578 hasConceptScore W3206421578C2776376669 @default.
• W3206421578 hasConceptScore W3206421578C2776850375 @default.
• W3206421578 hasConceptScore W3206421578C2777628635 @default.
• W3206421578 hasConceptScore W3206421578C2777682441 @default.
• W3206421578 hasConceptScore W3206421578C2777975735 @default.
• W3206421578 hasConceptScore W3206421578C2778198053 @default.
• W3206421578 hasConceptScore W3206421578C2778384902 @default.
• W3206421578 hasConceptScore W3206421578C2781069245 @default.
• W3206421578 hasConceptScore W3206421578C42219234 @default.
• W3206421578 hasConceptScore W3206421578C500558357 @default.
• W3206421578 hasConceptScore W3206421578C71924100 @default.
• W3206421578 hasConceptScore W3206421578C78085059 @default.
• W3206421578 hasIssue "4" @default.
• W3206421578 hasLocation W32064215781 @default.
• W3206421578 hasOpenAccess W3206421578 @default.
• W3206421578 hasPrimaryLocation W32064215781 @default.
• W3206421578 hasRelatedWork W1991159942 @default.
• W3206421578 hasRelatedWork W2039491607 @default.
• W3206421578 hasRelatedWork W2126699577 @default.
• W3206421578 hasRelatedWork W2193765730 @default.
• W3206421578 hasRelatedWork W2316047996 @default.
• W3206421578 hasRelatedWork W2368404399 @default.
• W3206421578 hasRelatedWork W3162043361 @default.
• W3206421578 hasRelatedWork W3201474475 @default.
• W3206421578 hasRelatedWork W4226076861 @default.
• W3206421578 hasRelatedWork W4362506950 @default.
• W3206421578 hasVolume "160" @default.
• W3206421578 isParatext "false" @default.
• W3206421578 isRetracted "false" @default.
• W3206421578 magId "3206421578" @default.
• W3206421578 workType "article" @default.